Gains from no real PAINS: Where ‘Fair Trial Strategy’ stands in the development of multi-target ligands
Sign Up to like & getrecommendations! Published in 2021 at "Acta Pharmaceutica Sinica B"
DOI: 10.1016/j.apsb.2021.02.023
Abstract: Abstract Compounds that selectively modulate multiple targets can provide clinical benefits and are an alternative to traditional highly selective agents for unique targets. High-throughput screening (HTS) for multitarget-directed ligands (MTDLs) using approved drugs, and fragment-based… read more here.
Keywords: fair trial; pains suspects; trial strategy; strategy ... See more keywords